Charles Schwab Investment Management Inc Selecta Biosciences Inc Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$1.04 - $1.4 $276,132 - $371,716	265,512 Added 444.03%	325,308 $364,000
Q2 2022 Aug 15, 2022	SELL	$0.67 - $1.4 $120,927 - $252,684	-180,489 Reduced 75.11%	59,796 $79,000
Q1 2022 May 13, 2022	BUY	$1.23 - $3.31 $13,015 - $35,026	10,582 Added 4.61%	240,285 $296,000
Q3 2021 Nov 16, 2021	BUY	$3.36 - $4.62 $21,974 - $30,214	6,540 Added 2.93%	229,703 $956,000
Q2 2021 Aug 16, 2021	BUY	$2.82 - $5.01 $124,426 - $221,056	44,123 Added 24.64%	223,163 $933,000
Q1 2021 May 17, 2021	SELL	$2.92 - $5.07 $40,024 - $69,494	-13,707 Reduced 7.11%	179,040 $811,000
Q4 2020 Feb 16, 2021	BUY	$1.64 - $3.42 $11,809 - $24,627	7,201 Added 3.88%	192,747 $585,000
Q3 2020 Nov 13, 2020	BUY	$2.18 - $2.84 $53,856 - $70,162	24,705 Added 15.36%	185,546 $461,000
Q2 2020 Aug 14, 2020	BUY	$1.83 - $4.06 $267,509 - $593,490	146,180 Added 997.07%	160,841 $457,000
Q3 2019 Nov 08, 2019	SELL	$1.6 - $2.08 $7,793 - $10,131	-4,871 Reduced 24.94%	14,661 $26,000
Q2 2019 Aug 09, 2019	SELL	$1.79 - $3.05 $126,689 - $215,866	-70,776 Reduced 78.37%	19,532 $35,000
Q1 2019 May 14, 2019	BUY	$1.47 - $3.06 $83,213 - $173,220	56,608 Added 167.98%	90,308 $215,000
Q4 2018 Feb 14, 2019	SELL	$2.66 - $15.93 $10,906 - $65,313	-4,100 Reduced 10.85%	33,700 $90,000
Q3 2018 Nov 13, 2018	BUY	$12.07 - $16.0 $49,487 - $65,600	4,100 Added 12.17%	37,800 $588,000
Q2 2018 Aug 08, 2018	BUY	$9.36 - $13.25 $85,176 - $120,575	9,100 Added 36.99%	33,700 $447,000
Q4 2017 Jan 17, 2018	SELL	$8.97 - $23.38 $44,850 - $116,900	-5,000 Reduced 16.89%	24,600 $242,000
Q3 2017 Nov 13, 2017	BUY	$15.22 - $20.03 $450,512 - $592,888	29,600	29,600 $541,000

Others Institutions Holding SELB

# of Institutions

Shares Held

4.67M

Call Options Held

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account